An overview of RNAi therapies

An overview of RNAi therapies

Slides in the pack:

1. Overview
2. RNAi mechanism
3. Key features of an RNAi therapeutics approach
4. Timeline of main events in RNAi therapeutics development
5. Alnylam: clinical development pipeline
6. Patisiran, an investigational RNAi therapeutic for the treatment of hereditary trans-thyretin mediated (hATTR) amyloidosis
7. Patisiran: APOLLO trial
8. hATTR Amyloidosis: market landscape and opportunity
9. More RNAi drugs in pipeline
10. Merck & Co, Novartis, Roche and other major players stopped RNAi based drug development